Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell”

7,954 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 7,954 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180
Testing effectiveness (Phase 2)Ended earlyNCT01061580
What this trial is testing

BMAC Enhanced Coronary Artery Bypass Grafting (CABG)

Who this might be right for
Congestive Heart Failure
Harvest Technologies 20
Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Very early researchEnded earlyNCT02653196
What this trial is testing

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

Who this might be right for
Neuroepithelial TumorSolid TumorAllogeneic Hematopoietic Stem Cell Transplantation
Montefiore Medical Center 1
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Not applicableStudy completedNCT00610415
What this trial is testing

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study

Who this might be right for
Head and Neck CancerHead and Neck Cancers
Stanford University 40
Testing effectiveness (Phase 2)UnknownNCT02709876
What this trial is testing

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Stem Cells Arabia 50
Early research (Phase 1)Study completedNCT02193191
What this trial is testing

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT02139280
What this trial is testing

Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 58
Not applicableLooking for participantsNCT07578480
What this trial is testing

MEN-ENDO: Menstrual Stem Cells in Endometriosis

Who this might be right for
Endometriosis
Francisco Algaba Chueca 40
Early research (Phase 1)WithdrawnNCT02579148
What this trial is testing

Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes

Who this might be right for
Erectile DysfunctionType 1 Diabetes MellitusType 2 Diabetes Mellitus
Leilei Zhu
Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Very early researchLooking for participantsNCT06565026
What this trial is testing

CS-206 in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
CorrectSequence Therapeutics Co., Ltd 5
Early research (Phase 1)UnknownNCT02409940
What this trial is testing

To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients

Who this might be right for
Renal Transplant Rejection
Post Graduate Institute of Medical Education and Research, Chandigarh 17
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Testing effectiveness (Phase 2)Study completedNCT00074997
What this trial is testing

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

Who this might be right for
HIV-1
Janssen-Cilag Pty Ltd 1
Not applicableStudy completedNCT01087515
What this trial is testing

Pilot Study for Cell Based Therapies in Patients With Asthma

Who this might be right for
AsthmaAllergic Rhinitis
Fraunhofer-Institute of Toxicology and Experimental Medicine 20
Large-scale testing (Phase 3)Study completedNCT00049517
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 657
Testing effectiveness (Phase 2)Ended earlyNCT00720850
What this trial is testing

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Technische Universität Dresden 10
Not applicableEnrolling By InvitationNCT05214742
What this trial is testing

Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders

Who this might be right for
Induced Pluripotent Stem Cells
Institute of Cardiometabolism and Nutrition, France 20
Load More Results